Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Total Debt (2016 - 2021)

International Stem Cell (ISCO) has disclosed Total Debt for 10 consecutive years, with $476000.0 as the latest value for Q2 2021.

  • On a quarterly basis, Total Debt changed N/A to $476000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $476000.0, a N/A change, with the full-year FY2020 number at $2.6 million, up 10.38% from a year prior.
  • Total Debt was $476000.0 for Q2 2021 at International Stem Cell, down from $1.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $2.8 million in Q3 2017 to a low of $351000.0 in Q1 2018.
  • A 5-year average of $1.5 million and a median of $1.7 million in 2018 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: surged 10476.92% in 2017, then plummeted 73.1% in 2018.
  • International Stem Cell's Total Debt stood at $2.8 million in 2017, then crashed by 36.55% to $1.7 million in 2018, then surged by 35.82% to $2.4 million in 2019, then rose by 10.38% to $2.6 million in 2020, then plummeted by 81.8% to $476000.0 in 2021.
  • Per Business Quant, the three most recent readings for ISCO's Total Debt are $476000.0 (Q2 2021), $1.1 million (Q1 2021), and $2.6 million (Q4 2020).